• Eng
  • Sve
Centre for Research Ethics & Bioethics (CRB)

Research at CRB



Our research deals with ethical, legal and social aspects of medicine and biology (bioethics) and the application of ethical principles and values to different scientific topics (research ethics).

Our research topics cover a wide range of ethical questions related to biobanks and registry research, ethical review, informed consent, medical treatment of patients, nursing, explanations of human consciousness, quality of life, end of life care and more.

The methods we use range from analytical philosophical methods to empirical studies using both qualitative and quantitative methods.

In 2011, Uppsala University conducted an overall evaluation of the University's research, "Quality and Renewal 2011" where we received a top quality grade.



 

Our research



PhD projects




Share |
CRB research news

EU data protection legislation threatens rare disease research

[2013-04-23] Research on rare diseases requires international collaboration and movement of samples and data across national borders. Currently the EU is discussing new data protection legislation that would make this type of research difficult. In the latest issue of Nature Review Genetics, Deborah Mascalzoni et al writes that the EU needs to make an exception for scientific research. Read more


Deborah Mascalzoni joins our team!

[2013-04-23] The latest addition to our group is Deborah Mascalzoni who joined our team of researchers in April this year.

Deborah Mascalzoni adds to our competence on the ethical issues related to biobank and registry research and brings new expertise on rare diseases. A perfect fit for CRB's role in the 7th framework project RD-Connect with a focus on rare diseases.
Read more


Patients pay the price for EU's data protection legislation

[2013-03-27] The European Union is suggesting new data protection legislation that, if it is passed, will seriously impair biomedical research. In an article in Lancet Oncology, Mats Hansson and a group of European researchers write that this his will have consequences for patients in the future. Read more

Blogpost about this article: Don’t shoot at the patient (or at the messenger)


More news from CRB >